This research paper focuses on ethical treatment of prisoners in the United States. Treatment of Prisoners and Virtue Ethics7 Importance of Ethics in Correctional Facility6
Virtue Ethics and Ethical Treatment in Prisons5 Published by Elsevier Inc.Ethical Issues: Ethical Treatment of PrisonersĮthical Theories of Utilitarianism and Deontology4
Incarceration Medication assisted treatment Overdose.Ĭopyright © 2019. Results highlight areas of exploration to influence treatment retention, including the role of probation/parole officers and the potential for peer support specialists to assist in reducing stigma and increasing interest in MAT. Results provide identification of novel factors, such as side effects, time between release and treatment linkage, and family and friends' opinions that influence MAT continuation post-incarceration. Participants reported reasons for why they did not continue MAT and had mixed intentions about continuing MAT in the future. Results indicate that most participants linked to MAT treatment post-release. The most commonly reported goal for treatment was to continue MAT long-term (43.5%). Those who did not connect with treatment post-release reported transportation issues (23.1%) and not wanting to continue MAT (20.5%) as major reasons for not continuing treatment. Most participants (82.4%) reported continuing MAT post-release and a majority (74.3%) received treatment at an opioid treatment program. Simple percentages, frequencies, means, and standard deviations were calculated with SPSS. Data relevant to demographic characteristics, probation/parole status, retention in MAT treatment, MAT type received during incarceration, MAT treatment history, location where they received community treatment, perceived barriers to treatment, and future goals for MAT were collected. Of the 588 individuals eligible for this study, 227 phone surveys were completed with 214 individuals. The objective of this study was to elucidate perceived barriers for individuals who participated in RIDOC's MAT program while incarcerated. The Rhode Island Department of Corrections (RIDOC) recently implemented the first state-wide, comprehensive medications for addiction treatment (MAT) program in the US.
0 kommentar(er)
